Bangladesh vs Moldova: Access to anti-retroviral drugs, male (%)
Bangladesh
45.0%
in 2024
Moldova
47.0%
in 2024
Bangladesh rank
125th
Moldova rank
122nd
Access to anti-retroviral drugs, male (%) over time
- Bangladesh
- Moldova
How they compare
Moldova currently reports 47.0% against 45.0% in Bangladesh, a difference of 2.0%.
Across all 25 years both countries report, Moldova has been ahead every year.
Bangladesh ranks 125th and Moldova ranks 122nd of 141 countries.
Moldova has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.9% | 1.4% | 0.5% | Moldova |
| 2010s | 13.0% | 16.0% | 3.0% | Moldova |
| 2020s | 36.4% | 39.2% | 2.8% | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bangladesh or Moldova?
- Moldova, at 47.0% against 45.0% in Bangladesh as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bangladesh and Moldova?
- 2.0%, with Moldova ahead.
- How many years of comparable data are there for Bangladesh and Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Moldova rank globally for access to anti-retroviral drugs, male?
- Bangladesh ranks 125th and Moldova ranks 122nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.